Ectdomain shedding and regulated intracellular proteolysis in the central nervous system.
The term Ectodomain Shedding (ES) refers to extracellular domain proteolytic release from cell membrane molecules. This proteolysis is mediated mainly by matrix metalloproteases (MMP) or disintegrin and metalloproteases (ADAM), although some other proteases may mediate it. Virtually, all functional categories of cell membrane molecules are subject of this kind of proteolysis, for this reason ES is involved in different cellular processes such as proliferation, apoptosis, migration, differentiation or pathologies such as inflammation, cancer and degeneration among others. ES releases membrane molecule's extracellular domain (or ectodomain) to the extracellular milieu where it can play different biological functions. ES of transmembrane molecules also generates membrane attached terminal fragments comprising transmembrane and intracellular domains that enable their additional processing by intracellular proteases known as Regulated Intracellular Proteolysis (RIP). This second proteolytic cleavage delivers molecule's intracellular domain (ICD) that carry out intracellular functions. RIP is mediated by the group of intracellular cleaving proteases (i-CLiPs) that include presenilin from the γ-secretase complex. In the CNS the best well known ES is that of the Amyloid Precursor Protein, although many other membrane molecules expressed by cells of the CNS are also subject to ES and RIP. In this review, these molecules are summarized, and some meaningful examples are highlighted and described. In addition, ES and RIP implications in the context of cell biology are discussed. Finally, some considerations that rise from the study of ES and RIP are formulated in view of the unexpected roles of intracellular fragments.
Montes de Oca-B
Pavel
P
Laboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía, D.F., México. pavel73@hotmail.com
D051722:ADAM Proteins / Q000378:metabolism / Q000502:physiology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism / Q000502:physiology*; D002490:Central Nervous System / Q000502:physiology*; D019483:Disintegrins / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D045726:Metalloproteases / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism / Q000502:physiology*
D016229:Amyloid beta-Peptides; D019483:Disintegrins; D045726:Metalloproteases; D010447:Peptide Hydrolases; D051722:ADAM Proteins; D020782:Matrix Metalloproteinases